Video
Author(s):
Rafael Fonseca, MD, shares his excitement for an upcoming AJMC Post-Conferences Perspectives video series covering the 2021 American Society of Hematology annual meeting.
Dual-Target CAR T Cells Achieve 100% Response Rate in MM
Myeloma Survivorship Program: Findings and Future Steps
Final GRIFFIN Trial Data Confirm Daratumumab Benefit Against MM
Advancements and Challenges in Treating Relapsed/Refractory Multiple Myeloma
Ide-Cel Generates Durable Responses in Functionally High-Risk Myeloma
The Tremendous Complexity of Treating RRMM